Part 7: Similarities and Differences
5 Sep 2023
Part 7: Similarities and Differences
Part 8: How PARP inhibitors are being used now
Part 9: What PARP inhibitors mean for the future and what to look out for
Global Focus on Cancer
Update from ASCO Breakthrough Asia Conference 2023
The impact of SEABCS 2023
AOH1996 treatment targeting PCNA shows promise for reoccurring solid tumours
Somatic and germline heterogeneity across colorectal cancer patient characteristics: Implications for early cancer detection
Sudan: Conflict, cancer care, and ripple effects on the region
Geriatric oncology in resource-limited settings
Updates on HR-positive HER2-negative breast cancer
Hodgkin’s and non-Hodgkin’s lymphomas (NHL)